We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+2.31%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$5.5B
AUM Growth
+$58M
Cap. Flow
-$11.2M
Cap. Flow %
-0.2%
Top 10 Hldgs %
36.95%
Holding
821
New
51
Increased
87
Reduced
185
Closed
82

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$25.4M
2
AMZN icon
Amazon
AMZN
+$17.1M
3
ROP icon
Roper Technologies
ROP
+$14.2M
4
TEL icon
TE Connectivity
TEL
+$12.1M
5
MSFT icon
Microsoft
MSFT
+$9.04M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$11.6M
2
TJX icon
TJX Companies
TJX
+$10.8M
3
JNJ icon
Johnson & Johnson
JNJ
+$8.91M
4
PG icon
Procter & Gamble
PG
+$8.9M
5
META icon
Meta Platforms (Facebook)
META
+$8.24M

Sector Composition

Rank Sector Weight
1 Technology 27.8%
2 Healthcare 17.78%
3 Financials 10.19%
4 Consumer Staples 9.56%
5 Consumer Discretionary 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHH
651
DELISTED
PHH Corporation
PHH
$3K ﹤0.01%
325
– –
CALD
652
DELISTED
Callidus Software, Inc.
CALD
$3K ﹤0.01%
73
– –
AMG icon
653
Affiliated Managers Group
AMG
$9.57B
$2K ﹤0.01%
9
– –
ASIX icon
654
AdvanSix
ASIX
$427M
$2K ﹤0.01%
64
– –
AWK icon
655
American Water Works
AWK
$26.8B
$2K ﹤0.01%
22
– –
CDNS icon
656
Cadence Design Systems
CDNS
$89B
$2K ﹤0.01%
42
– –
CMS icon
657
CMS Energy
CMS
$22B
$2K ﹤0.01%
37
– –
FHN icon
658
First Horizon
FHN
$12.3B
$2K ﹤0.01%
124
– –
FIVN icon
659
FIVE9
FIVN
$2.33B
$2K ﹤0.01%
58
– –
GPN icon
660
Global Payments
GPN
$23.4B
$2K ﹤0.01%
18
– –
PPLI
661
People Inc
PPLI
$3.02B
$2K ﹤0.01%
62
– –
IFF icon
662
International Flavors & Fragrances
IFF
$21.4B
$2K ﹤0.01%
11
– –
IPG
663
DELISTED
Interpublic Group of Companies
IPG
$2K ﹤0.01%
70
– –
IWR icon
664
iShares Russell Mid-Cap ETF
IWR
$57.9B
$2K ﹤0.01%
44
– –
MKL icon
665
Markel Group
MKL
$22.8B
$2K ﹤0.01%
2
– –
NDAQ icon
666
Nasdaq
NDAQ
$53.5B
$2K ﹤0.01%
69
– –
NEU icon
667
NewMarket
NEU
$8.59B
$2K ﹤0.01%
4
– –
RF icon
668
Regions Financial
RF
$26.9B
$2K ﹤0.01%
112
– –
RVTY icon
669
Revvity
RVTY
$13.2B
$2K ﹤0.01%
26
– –
SNPS icon
670
Synopsys
SNPS
$79B
$2K ﹤0.01%
25
– –
SPR
671
DELISTED
Spirit AeroSystems
SPR
$2K ﹤0.01%
25
– –
SRE icon
672
Sempra
SRE
$56.2B
$2K ﹤0.01%
28
– –
STZ icon
673
Constellation Brands
STZ
$22.9B
$2K ﹤0.01%
9
– –
TFX icon
674
Teleflex
TFX
$5.78B
$2K ﹤0.01%
8
– –
WTFC icon
675
Wintrust Financial
WTFC
$11B
$2K ﹤0.01%
18
– –
25 26
27
28 29

Similar funds

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Loring Wolcott & Coolidge Fiduciary Advisors held 821 positions worth $5.5B, up 1.1% from $5.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2018 filing shows 51 new, 87 increased, 185 reduced and 82 closed positions. Its largest new stake was Diamondback Energy: 3,285 shares worth $416K. The largest sale was Novo Nordisk, an estimated $11.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q1 2018 buy was Diamondback Energy: 3,285 shares worth $416K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Becton Dickinson in Q1 2018, an estimated $25.4M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q1 2018 reduction was Novo Nordisk, cutting an estimated $11.6M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $229K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 37% of its $5.5B portfolio in Q1 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 51 new positions and closed 82 in Q1 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 1.1% quarter-over-quarter to $5.5B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2018, filed 20 Apr 2018.